This brand name is authorized in New Zealand, United Kingdom
The drug FERROGRAD C contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Ferrous sulfate
UNII 39R4TAN1VT - FERROUS SULFATE
|
|
Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen. |
|
2
Vitamin C
UNII PQ6CK8PD0R - ASCORBIC ACID
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AE10 | Various combinations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AE Iron in other combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 49135 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 8516 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
